94% sensitivity
Frontiers in Aging Neuroscience, 2023
354 peer-reviewed papers
Collective research output
37,000+ citations
Scientific community recognition
The clinical foundation behind every assessment, every result, and every care plan
Neurotrack’s cognitive care enablement platform is built on more than a decade of peer-reviewed research, clinical validation, and scientific rigor. Every capability in the platform traces directly to published science, validated methodology, and ongoing clinical investigation.
The science behind the numbers
Depth of science that took decades to build
25+
Core company studies published
11
Patents protecting Neurotrack’s proprietary technology
354
Peer-reviewed papers authored collectively by Neurotrack’s co-founders and clinical team
$4.3M
In grants awarded by the National Institute on Aging, ADDF, and Georgia Research Alliance.r
Built on pioneering science
A founding team whose research defined the field
Neurotrack’s science is rooted in the work of cognitive neuroscience pioneer Dr. Stuart Zola and a founding team whose collective research has been published 354 times and cited more than 37,000 times. That body of work underpins every assessment and every clinical output in the platform.
Here is a selection of the most significant published studies.
Clinical Validation Studies
Frontiers in Aging Neuroscience
2023
Neurotrack cognitive assessment battery delivers 94% sensitivity and 90% specificity, exceeding Alzheimer's Association guidelines for Brief Cognitive Assessments.
JMIR Aging
2023
Validation study confirms Neurotrack’s digital screening meets gold standard measures for cognitive assessment.
JMIR Formative Research
2022
Neurotrack’s digital assessments demonstrate reliability for repeat use, supporting routine annual cognitive screening.
Detection & Methodology Studies
Alzheimer’s Disease and Other Dementias
2013
Foundational study demonstrating that a computerized visual task predicts conversion to MCI and Alzheimer’s disease.
Geroscience
2022
Neurotrack assessment approach demonstrates reliable detection of cognitive change across diverse patient populations.
Journal of Prevention of Alzheimer’s Disease
2021
Neurotrack identifies and accounts for environmental distraction signals in remote cognitive testing, maintaining assessment integrity outside clinical settings.
Remote and Real-world deployment studies
JMIR Aging
2022
Neurotrack cognitive assessments validated for asynchronous remote administration, confirming accuracy and reliability without clinical supervision.
Frontiers in Aging Neuroscience
2023
Assessment battery validated across diverse populations including underrepresented groups, supporting deployment in varied clinical and community settings.
Research partners
The institutions that trust our science
Neurotrack is committed to closing the cognitive care confidence gap, not just through clinically validated assessments and Smart Logic, but through the education and resources that help providers feel equipped to manage one of the fastest growing needs in primary care. The number of people living with MCI and dementia is growing faster than most primary care practices were trained to handle, and we believe the tools and the training should come together.
Full Publications Library
Every study, organized by category
A complete curation of studies in each category confirmed with our clinical and science teams lorem ipsum dolor sit amet nec tempor id, iaculis vitae felis.
Efficacy and practicality of the Neurotrack cognitive assessment battery
August, 2023
Japan has the largest aging population with 33% of the population over the age of 60 years. The number of Japanese adults with dementia is estimated to be approximately 4.6 million, comprising nearly 15% of the older adult population.
A novel digital digit-symbol substitution test measuring processing speed in adults at-risk for Alzheimer’s disease: Validation study
January, 2023
Assessing cognitive constructs affected by Alzheimer disease, such as processing speed (PS), is important to screen for potential disease and allow for early detection.
The use of digital technology to assess cognitive function in Tunisian adults
August, 2022
There has been increasing evidence and support for the use of digital technology in the cognitive health field. Despite the growing use of innovative digital technology to assess cognitive function, such technology remains scarce in Arabic countries, particularly in Tunisia.
Asynchronous remote assessment for cognitive impairment: reliability verification of the Neurotrack Cognitive Battery
February, 2022
As evidenced by the further reduction in access to testing during the COVID-19 pandemic, there is an urgent, growing need for remote cognitive assessment for individuals with cognitive impairment.
Environmental distractions during unsupervised remote digital cognitive assessment
March, 2021
The current demand for cognitive assessment cannot be met with traditional in-person methods, warranting the need for remote unsupervised options.
A short digital eye-tracking assessment predicts cognitive status among adults
September, 2020
Current cognitive assessments suffer from limited scalability and high user burden. This study aimed to (1) examine the relationship between a brief eye-tracking-based visual paired-comparison (VPC) and gold standard cognitive assessments...
Device-embedded cameras for eye tracking-based cognitive assessment: Implications for teleneuropsychology
April, 2020
Widespread screening for cognitive decline is an important challenge to address as the aging population grows, but there is currently a shortage of clinical infrastructure to meet the demand for in-person evaluation.
Validation of a digitally-delivered visual paired comparison task
August, 2019
Alzheimer's disease (AD) affects the memory and cognitive function of approximately 5.7 million Americans. Early detection subsequently allows for earlier treatment and improves outcomes.
Device-embedded cameras for eye tracking–based cognitive assessment: Validation with paper-pencil and computerized cognitive composites
May, 2018
As eye tracking-based assessment of cognition becomes more widely used in older adults, particularly those at risk for dementia, reliable and scalable methods to collect high-quality data are required.
Web camera based eye tracking to assess visual memory on a visual paired comparison task
June, 2017
Web cameras are increasingly part of the standard hardware of most smart devices. Eye movements can often provide a noninvasive “window on the brain,” and the recording of eye movements using web cameras is a burgeoning area of research.
A behavioral task predicts conversion to mild cognitive impairment and Alzheimer’s disease
March, 2013
Currently, we cannot reliably differentiate individuals at risk of cognitive decline, for example, mild cognitive impairment (MCI), Alzheimer’s disease (AD), from those individuals who are not at risk.
The effect of a digital health coaching and health education protocol on cognition in adults at-risk for Alzheimer’s
April, 2023
Several modifiable lifestyle factors have been linked to cognitive ability and the risk of developing Alzheimer's disease and related dementias (ADRD).
Intervention for a digital, cognitive, multi-domain Alzheimer's risk velocity study: Protocol for a randomized controlled trial
February, 2022
In the United States, more than 6 million adults live with Alzheimer disease (AD) that affects 1 out of every 3 older adults.
Cognitive decline negatively impacts physical function
January, 2021
Many older adults report difficulty performing one or more activities of daily living. These difficulties may be attributed to cognitive decline and as a result, measuring cognitive status among aging adults may help provide an understanding of current functional status.
Risk reduction and prevention of Alzheimer's disease: Biological mechanisms of diet
January, 2020
Alzheimer's Disease (AD) incidence is increasing and with no disease modifying agents available, preventative measures through lifestyle factors are being investigated.
Engagement with a digital platform for multimodal cognitive assessment and multidomain intervention in a Japanese population
October, 2019
As the global prevalence of dementia continues to rise, multidomain lifestyle interventions that address modifiable risk factors associated with pathological cognitive decline are increasing.
Face-to-face and digital multidomain lifestyle interventions to enhance cognitive reserve and reduce risk of Alzheimer's disease and related dementias
September, 2019
Currently, there is no pharmaceutical intervention to treat or delay pathological cognitive decline or Alzheimer's disease and related dementias (ADRD).
Prevention and treatment of Alzheimer's disease: Biological mechanisms of exercise
May, 2019
Alzheimer’s disease (AD) is the most common form of dementia. With an aging population and no disease modifying treatments available, AD is quickly becoming a global pandemic.
The impact of the Virtual Cognitive Health (VC Health) Program on cognition and mental health for older adults
August, 2018
Face-to-face multidomain lifestyle interventions have shown to be effective for improving or maintaining cognitive function in older adults at risk for dementia.
A remote intervention to prevent or delay cognitive impairment in older adults: Design, recruitment, and baseline characteristics of the Virtual Cognitive Health (VC Health) study
June, 2018
A growing body of evidence supports the use of lifestyle interventions for preventing or delaying the onset of Alzheimer disease and other forms of dementia in at-risk individuals.
Time-restricted feeding and cognitive function in sedentary and physically active older people: Ramadan intermittent fasting as a model
November, 2022
This study aimed to investigate the effects of Ramadan diurnal intermittent fasting (RDIF) on cognitive performance, sleep quality, daytime sleepiness, and insomnia in physically active and sedentary elderly individuals.
A study of novel exploratory tools, digital technologies, and central nervous system biomarkers to characterize unipolar depression
May, 2021
Digital technologies have the potential to provide objective and precise tools to detect depression-related symptoms.
Acute inositol-stabilized arginine silicate improves cognitive outcomes in young adults
November, 2021
Inositol-stabilized arginine silicate (ASI) is an ergogenic aid that upregulates nitric oxide. Acute ASI supplementation improves working memory and processing speed in young adults but there is a lack of data examining other cognitive tasks.
The Digital Choice Anxiety Survey (DCAS): initial development and validation
December, 2020
Psychiatric symptomatology, including anxiety, partially comprise theclinical prodrome of dementia. Moreover, increased anxiety may represent a risk fac-tor associated with neurodegenerative disease.
Dietary protein and amino acid intake: Links to the maintenance of cognitive health
June, 2019
With the rapid growth in the aging population, there has been a subsequent increase in the rates of Alzheimer’s disease and related dementias (ADRD).
The science is there. See how it translates into practice.
Every published study, every validated methodology, and every peer-reviewed finding behind Neurotrack translates directly into clinical capability. See the platform in action or talk to our team about the science behind it.
Have questions?
Talk to our team